New treatments in age-related macular degeneration. (Q31004243)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14516424 AND SRC:MED&resulttype=core&format=json

19 December 2019

review article

1 reference

title

New treatments in age-related macular degeneration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14516424 AND SRC:MED&resulttype=core&format=json

19 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14516424 AND SRC:MED&resulttype=core&format=json

19 December 2019

author name string

Claire Y Hooper

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14516424 AND SRC:MED&resulttype=core&format=json

19 December 2019

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14516424 AND SRC:MED&resulttype=core&format=json

Clinical and Experimental Ophthalmology

19 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14516424 AND SRC:MED&resulttype=core&format=json

19 December 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14516424 AND SRC:MED&resulttype=core&format=json

19 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14516424 AND SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

376-391

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14516424 AND SRC:MED&resulttype=core&format=json

Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

The prevalence of age-related maculopathy: the visual impairment project

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Age-specific causes of bilateral visual impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Early detection, diagnosis and management of choroidal neovascularization in age-related macular degeneration: the role of ophthalmologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Phase I/II study of proton beam irradiation for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: treatment techniques and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Proton beam irradiation of subfoveal choroidal neovascularisation in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Radiotherapy for choroidal neovascularisation of age-related macular degeneration: a fresh perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Radiation therapy for subretinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

External radiotherapy in macular degeneration: technique and preliminary subjective response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Radiotherapy for age-related macular degeneration: preliminary results of a potentially new treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

External Radiotherapy in Macular Degeneration: Our Technique, Dosimetric Calculation, and Preliminary Results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Randomized trial of radiation for age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Transpupillary thermotherapy in choroidal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Transpupillary thermotherapy for choroidal melanoma: tumor control and visual results in 100 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Transpupillary thermotherapy as primary treatment for small choroidal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Natural course of poorly defined choroidal neovascularization associated with macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Retinal pigment epithelial tear after transpupillary thermotherapy for choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Thalidomide and prednisolone inhibit growth factor-induced human retinal pigment epithelium cell proliferation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Regression of Experimental Iris Neovascularization with Systemic Alpha-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

The treatment of choroidal neovascular membranes by alpha interferon. An efficacy and toxicity study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

External argon laser choroidotomy for subretinal fluid drainage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Tissue plasminogen activator thrombolysis during surgical evacuation of experimental subretinal hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Pathophysiology and management of subretinal hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Submacular hemorrhage removal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Clinical experience with the surgical removal of subfoveal neovascular membranes. Short-term postoperative results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Surgical extraction of subfoveal choroidal new vessels and submacular haemorrhage in age-related macular degeneration: results of a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Retinal cell transplantation in the macula: new techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Comparative study of ROS degradation by IPE and RPE cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Translocation of the Retina for Management of Subfoveal Choroidal Neovascularization II: A Preliminary Report in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Anatomic and functional recovery of the fovea after foveal translocation surgery without large retinotomy and simultaneous excision of a neovascular membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Retinotomy and foveal translocation for surgical management of subfoveal choroidal neovascular membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Macular translocation for surgical management of subfoveal choroidal neovascularizations in patients with AMD: first results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Macular translocation: unifying concepts, terminology, and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Limited macular translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Complications associated with limited macular translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

The Grading and Prevalence of Macular Degeneration in Chesapeake Bay Watermen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

The prevalence of age-related maculopathy in the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Radiotherapy treatment of age-related subfoveal neovascular membranes in patients with good vision

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

External beam radiation in patients suffering from exudative age-related macular degeneration. A matched-pairs study and 1-year clinical follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Radiotherapy for subfoveal choroidal neovascularization in age-related macular degeneration: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: radiation versus observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Radiation-associated choroidal neovasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Transpupillary thermotherapy for small choroidal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Hypoxic regulation of vascular endothelial growth factor in retinal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Systemic antiangiogenic therapy for choroidal neovascularization. What is the role of interferon alfa?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Interferon alpha 2a for treatment of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Interferon alpha‐2a treatment of patients with subfoveal neovascular macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Intravitreal triamcinolone and elevated intraocular pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Factors prognostic of visual outcome in patients with subretinal hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Variations in the clinical course of submacular hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Fibrin directs early retinal damage after experimental subretinal hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Tissue Plasminogen Activator Treatment of Experimental Subretinal Hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Subretinal hemorrhage management by pars plana vitrectomy and internal drainage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Surgical management of submacular hemorrhage. A series of 47 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Retinal toxicity of recombinant tissue plasminogen activator in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

The effect of tissue plasminogen activator on retinal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Long-term outcomes after the surgical removal of advanced subfoveal neovascular membranes in age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Visual results after surgical removal of subfoveal choroidal neovascular membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Tissue plasminogen activator-assisted surgical excision of subfoveal choroidal neovascularization in age-related macular degeneration: a randomized, double-masked trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Chorioretinal damage caused by the excision of choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1442-9071.2003.00683.X

10.1046/J.1442-9071.2003.00683.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14516424 AND SRC:MED&resulttype=core&format=json

release_nsiywgidqvh75i2zkqvam45vpu

19 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nsiywgidqvh75i2zkqvam45vpu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference